DSM-Firmenich experienced significant insider activity in February 2026, characterized by multiple board members executing substantial share purchases. These acquisitions, occurring between February 12 and February 20, represent the most recent transactions. Prior to this period, executive leadership engaged in divestments during April 2025, marking a shift in internal trading patterns.